urokinase-type plasminogen activator inhibitors (Curacyte)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameurokinase-type plasminogen activator inhibitors (Curacyte)
Drug Alias NameCJ-463
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrokinase plasminogen activator inhibitors
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCuracyte AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuracyte AG
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A